Home
/
Wave Life Sciences Ltd.
/
Financials
/
Quarterly
Wave Life Sciences Ltd. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Wave Life Sciences Ltd. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$1.42M
May 9, 2018
Q3
2017
Sep 30, 2017
$676.0K
Nov 9, 2017
Q2
2017
Jun 30, 2017
$676.0K
Aug 9, 2017
Q1
2018
Mar 31, 2017
$383.0K
May 9, 2018
Q3
2017
Sep 30, 2016
$392.0K
Nov 9, 2017
Q2
2017
Jun 30, 2016
$417.0K
Aug 9, 2017
Q3
2016
Sep 30, 2015
$152.0K
Nov 9, 2016
Q2
2016
Jun 30, 2015
$126.0K
Aug 15, 2016
Q1
2016
Mar 31, 2015
$26.0K
May 16, 2016
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2025
Jun 30, 2025
$8.70M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$9.18M
May 8, 2025
Q2
2025
Jun 30, 2024
$19.69M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$12.54M
May 8, 2025
Q3
2023
Sep 30, 2023
$49.21M
Nov 9, 2023
Q2
2024
Jun 30, 2023
$22.11M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$12.93M
May 10, 2024
Q3
2023
Sep 30, 2022
$285.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$375.0K
Aug 3, 2023
Q1
2023
Mar 31, 2022
$1.75M
May 3, 2023
Q3
2022
Sep 30, 2021
$36.42M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$2.78M
Aug 11, 2022
Q3
2021
Sep 30, 2020
$3.45M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$3.03M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$4.16M
May 13, 2021
Q3
2020
Sep 30, 2019
$2.93M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$7.63M
Aug 10, 2020
Q1
2020
Mar 31, 2019
$3.03M
May 11, 2020
Q3
2019
Sep 30, 2018
$4.49M
Nov 5, 2019
Q2
2019
Jun 30, 2018
$4.88M
Aug 6, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($53.85M)
Nov 10, 2025
Q3
2025
Jun 30, 2025
($50.47M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($50.47M)
Jul 30, 2025
Q2
2025
Mar 31, 2025
($46.88M)
Jul 30, 2025
Q1
2025
Mar 31, 2025
($46.88M)
May 8, 2025
Q3
2025
Mar 31, 2025
($46.88M)
Nov 10, 2025
Q3
2025
Sep 30, 2024
($61.78M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($32.92M)
Jul 30, 2025
Q3
2025
Jun 30, 2024
($32.92M)
Nov 10, 2025
Q1
2025
Mar 31, 2024
($31.56M)
May 8, 2025
Q3
2025
Mar 31, 2024
($31.56M)
Nov 10, 2025
Q2
2025
Mar 31, 2024
($31.56M)
Jul 30, 2025
Q3
2024
Sep 30, 2023
$7.25M
Nov 12, 2024
Q3
2024
Jun 30, 2023
($21.10M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($21.10M)
Aug 8, 2024
Q2
2024
Mar 31, 2023
($27.41M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($27.41M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($27.41M)
May 10, 2024
Q3
2023
Sep 30, 2022
($39.00M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($41.30M)
Aug 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($56.35M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($52.76M)
Jul 30, 2025
Q1
2025
Mar 31, 2025
($49.80M)
May 8, 2025
Q3
2025
Sep 30, 2024
($63.92M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($35.00M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($34.46M)
May 8, 2025
Q3
2024
Sep 30, 2023
$4.44M
Nov 12, 2024
Q2
2024
Jun 30, 2023
($23.47M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($30.29M)
May 10, 2024
Q3
2023
Sep 30, 2022
($38.90M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($42.16M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($38.09M)
May 3, 2023
Q3
2022
Sep 30, 2021
($7.61M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($39.83M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($43.47M)
May 12, 2022
Q3
2021
Sep 30, 2020
($34.42M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($38.66M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($49.99M)
May 13, 2021
Q3
2020
Sep 30, 2019
($54.18M)
Nov 9, 2020
Q2
2020
Jun 30, 2019
($45.62M)
Aug 10, 2020